Target intelligence / Profile preview

Neurocognitive modulation

Molecular classification
Not applicable directly, G protein-coupled receptors (GPCRs), Ion channels, Neurotransmitter receptors
01

Overview

Neurocognitive modulation refers broadly to the alteration or normalization of nervous system activity specifically aimed at improving cognitive functions through endogenous or exogenous means. This can be achieved by delivering targeted stimuli—electrical currents (e.g., transcranial magnetic stimulation), chemical agents directly into neurological sites—or using feedback systems like neurofeedback that train individuals to self-regulate brain activity patterns associated with cognition. Neuromodulatory processes involve complex interactions between neurons mediated by chemicals such as dopamine, serotonin, acetylcholine acting primarily on metabotropic G-protein coupled receptors leading to long-lasting changes in neuronal excitability and synaptic efficacy. These changes can enhance learning capacity, memory formation, emotional regulation abilities among other higher-order brain functions. Clinically applied neuromodulation therapies have shown promise across several neurological conditions where cognitive deficits are prominent—including Alzheimer's disease—and psychiatric illnesses characterized by dysregulated emotional processing such as depression. Techniques range from invasive implanted devices delivering electrical pulses deep within the brain structures implicated in cognition up to non-invasive approaches like transcranial direct current stimulation (tDCS). Research continues into optimizing these interventions' precision based on individual biomarkers derived from imaging modalities alongside understanding fundamental biological mechanisms underpinning successful neurocognitive enhancement through these modulatory approaches.

Other names
Neuromodulation of cognitive functionEndogenous neuromodulationNeurofeedback-related neuromodulation (in some contexts)
02

Mechanism of action

N/A directly; but underlying mechanisms include: Modulating neurotransmitter systems that influence cognition via GPCR signaling cascades affecting neuronal firing rates and synaptic plasticity.

03

Biological functions

Modulation of neural circuit excitability and firing patternsRegulation of neurotransmitter release (dopamine, serotonin, acetylcholine etc.)Cognitive processes including attention, memory, emotion regulation via targeted brain areas such as amygdalaPlasticity and network reconfiguration in the central nervous system
04

Disease associations

Neurodegenerative diseases (e.g., Alzheimer's disease)Psychiatric disorders including depression and anxiety disordersChronic pain managementEpilepsy resistant to medication treatmentMovement disorders such as Parkinson’s disease and Tourette syndrome
05

Safety considerations

Challenges relate mostly to invasive vs non-invasive delivery methods for electrical/magnetic stimulation devices including risks from implantation procedures or off-target effects from stimulation parametersDrug tolerance/addiction issues may arise when pharmacological agents are used adjunctivelyPrecise dosing ("stimulation dose") standardization remains an ongoing challenge
06

Interacting drugs

Dopaminergic agents (used adjunctively)

2 more in the full profile.

07

Biomarkers

fMRI-based measures like Amygdala Electrical Fingerprint (Amyg-EFP)

Beyond the preview

Go deeper on Neurocognitive modulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurocognitive modulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call